News Concordia hiked drug price by 6,000%, says UK watchdog CMA provisionally finds Concordia overpriced thyroid drug.
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
News EU authorities accuse Teva of breaking competition rules Teva accused of "pay for delay" deal with Cephalon.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.